Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency by Amy E. Lovejoy, Tom C. Reynolds, Jennifer E. Visich, Michael D. Butine, Guy Young, Melissa A. Belvedere, Rachelle C. Blain, Susan M. Pederson, Laura M. Ishak, and Diane J. Nugent Blood Volume 108(1):57-62 July 1, 2006 ©2006 by American Society of Hematology Activity and concentrations of FXIII after infusion of 20, 50, or 75 U/kg rFXIII in patients with FXIII deficiency. Amy E. Lovejoy et al. Blood 2006;108:57-62 ©2006 by American Society of Hematology Thromboelastography results for patient 8 and patient 9. Amy E. Lovejoy et al. Blood 2006;108:57-62 ©2006 by American Society of Hematology Thromboelastography results for patient 8. Amy E. Lovejoy et al. Blood 2006;108:57-62 ©2006 by American Society of Hematology